Zydus receives approval from DCGI for Saroglitazar Magnesium for treatment of Type II Diabetes

▴ Zydus
Zydus’ Saroglitazar Magnesium has been approved for the treatment of diabetes mellitus type 2 by the Drug Controller General of India

Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has received the approval from the Drug Controller General of India for use of Saroglitazar Mg in the treatment of Type II Diabetes Mellitus as an add on therapy with Metformin. The drug was previously approved in the year 2013 for the treatment of ypertriglyceridemia and Diabetic Dyslipidemia in India. More than 1 Million patients are being treated with LipaglynTM.

The Diabetes Phase 3 clinical trial was a Multi-centric, Prospective, Randomized, Double- blind Study to Evaluate the Safety and Efficacy of Saroglitazar Mg 2 mg and 4 mg as compared to Pioglitazone 30 mg in patients with type 2 diabetes. The Phase 3 trial conducted in 1140 type 2 diabetes patients for a total of 56 weeks met the primary end-points (CTRI/2015/09/006203). The primary outcome measure was the change from baseline in glycosylated hemoglobin (HbA1c) for Saroglitazar 4 mg, 2 mg and Pioglitazone 30 mg at 24 weeks. The secondary outcome measures hange from baseline in fasting plasma glucose, 2 hour postprandial plasma glucose, lipid profile, Triglyceride (TG) cholesterol, Low density lipoprotein (LDL) cholesterol, Very low density lipoprotein (VLDL) cholesterol, High density lipoprotein (LDL) cholesterol, Total cholesterol (TC) cholesterol, Non HDL cholesterol, Apolipoprotein (Apo) A1 and Apo B between Saroglitazar (4 mg, 2 mg) and Pioglitazone (30 mg) treatment at Week 12, 24 and 56.


In Phase III diabetes trial, at 24 weeks, HbA1c was reduced by 1.38 g/dL with Saroglitazar 2 mg, 1.47 g/dL with Saroglitazar 4 mg and 1.41 g/dL with Pioglitazone 30 mg. At 56 weeks, HbA1c reduced by 1.34 g/dL with Saroglitazar 2 mg, 1.49 g/dL with Saroglitazar 4 mg and 1.47 g/dL with Pioglitazone 30 mg. Saroglitazar did not cause ypoglycemia or weight gain in this trial.


“Insulin resistance is one of the primary causes of diabetes and there is a huge unmet medical need for a safe and effective insulin sensitizer. Saroglitazar is an important scientific and medical breakthrough in our effort to develop medicines for patients suffering from Type 2 diabetes mellitus. With the increasing cases of diabetes in India, the need to strengthen diabetes management and help patients control their blood sugar levels is of critical importance.” mentioned Pankaj Patel, Chairman, Zydus Group.

Saroglitazar (Lipaglyn™), is a novel PPARα/γ agonist having predominant PPAR alpha activity. The recommended dose of Lipaglyn™ is 4 mg once-a-day. Lipaglyn™ is a prescription drug and should be taken under guidance of a registered medical practitioner. Lipalgyn™ was first launched in India during September 2013. Over the last several years, more than 1 Million patients have been treated with Lipaglyn™ in India for management of Hypertriglyceridemia and Diabetic Dyslipidemia, and data has been presented at several scientific and medical conferences.

Tags : #Zydus #Type2diabetes #Drug #Controller #General #India #Medicircle

About the Author


Team Medicircle

Related Stories

12 Mar

Amrita students win first prize at DecodeX 2025 hackathon

The victory marks a significant achievement for Amrita Vishwa Vidyapeetham, further strengthening its presence in competitive technology-driven events at the national level.

View
11 Oct

Not Just a Day, But a Movement: The Real Impact of International Girl Child Day in India

International Girl Child Day serves as a reminder that girls are not just beneficiaries of development but drivers of change.

View
10 Oct

DKMS BMST Foundation India Expands Stem Cell Donor Registry with 400+ New Donors registered from IIT Delhi

DKMS BMST Foundation India, a non-profit organization dedicated to the fight against blood cancer and disorders collaborated with IIT Delhi’s cultural festival Rendezvous 2024 as the social initiative partner, driving an impactful stem cell donor registration campaign that garnered an overwhelming participation, with over 400 students registering as potential stem cell donors.

View
12 Jul

Alarming Rise in Death's Due to HIV Among Students in Tripura: Urgent Need for Action

The rise in HIV cases among students is not just a health crisis but a social one as well. It affects families, communities, and the educational environment.

View
06 Jul

The Impact of Architecture on Academic Performance: How Exam Hall Design Affects Student Success

This study reveals how the design of a space can affect task performance, showing that students perform relatively poorly in their exams when they take them in large rooms with high ceilings.

View
30 Oct

World Mental Health Day - Quote from Dr. Skand Bali_The Hyderabad Public School, Begumpet

According to the National Mental Health Survey 2016, the prevalence of mental disorders among children aged 13–17 years is 7.3%. These disorders include depressive disorders (2.6%) and anxiety disorders (1.3%). The economic burden of neuropsychiatric disorders in India is estimated to be as high as 4% of the gross national product (GNP), with nearly 2% allocated to treating mentally ill individuals. These statistics underscore the urgency of addressing mental health issues among children and adolescents.

View
05 Oct

UMMEED Guidelines: A Step Towards Student Wellness and Safety

These guidelines foster an inclusive environment where students are supported by educators, parents, and UMMEED's school wellness teams, promoting a healthier, happier student community.

View
25 Sep

Silver Oaks International Schools to provide succor to the underprivileged through its ‘Silver Oaks Street Store’ initiative!

Silver Oaks International School students are gathering unused items, including clothes, books, and toys, to create a Street Store accessible to the underprivileged on September 24, 2023, from 9 am to noon.

View
23 Sep

Puducherry Government's Noble Initiative: Empowering Underprivileged Students in Medical Education

This initiative sends a powerful message about the importance of educational equity and inclusivity. It highlights the belief that every student with the talent and determination to pursue a career in medicine should have the opportunity to do so without the stress of financial constraints.

View
15 Sep

World Suicide Prevention Day webinar : Addressing Mental Health Issues Among Students

Recent reports show that over the past seven months, at least 20 cases of suicide have been reported among students in central education institutions.

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025